Mary Ann Ndiaye

Mary Ann Ndiaye

University of Wisconsin-Madison

H-index: 23

North America-United States

About Mary Ann Ndiaye

Mary Ann Ndiaye, With an exceptional h-index of 23 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Wisconsin-Madison, specializes in the field of Cancer Biology, Cancer Prevention, Molecular Cancer Targets.

His recent articles reflect a diverse array of research interests and contributions to the field:

A potential oncogenic role and immunoregulatory mechanisms of MZB1 in melanoma

Role of PLK1/NUMB/NOTCH in epithelial-mesenchymal transition in human melanoma

Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer

Abstract LB017: Potential role of kinesin family member C1 (KIFC1) in melanoma

Abstract LB019: DUSP4 overexpression exerts anti-tumor effects in vivo in pancreatic cancer xenografts in nu/nu mice

Abstract LB018: Therapeutic efficacy of inhibition of specific sirtuins against melanoma in BrafV600E/PtenNULL and PDX models

A potential pro-oncogenic role of SERPINB4 in melanoma

Protective effects of dietary grape against atopic dermatitis-like skin lesions in NC/NgaTndCrlj mice

Mary Ann Ndiaye Information

University

Position

Research Specialist

Citations(all)

2982

Citations(since 2020)

1920

Cited By

1806

hIndex(all)

23

hIndex(since 2020)

19

i10Index(all)

34

i10Index(since 2020)

31

Email

University Profile Page

Google Scholar

Mary Ann Ndiaye Skills & Research Interests

Cancer Biology

Cancer Prevention

Molecular Cancer Targets

Top articles of Mary Ann Ndiaye

A potential oncogenic role and immunoregulatory mechanisms of MZB1 in melanoma

Cancer Research

2024/3/22

Role of PLK1/NUMB/NOTCH in epithelial-mesenchymal transition in human melanoma

NPJ Precision Oncology

2024/1/6

Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer

Cancers

2023/11/17

Abstract LB017: Potential role of kinesin family member C1 (KIFC1) in melanoma

Cancer Research

2023/4/14

Abstract LB019: DUSP4 overexpression exerts anti-tumor effects in vivo in pancreatic cancer xenografts in nu/nu mice

Cancer Research

2023/4/14

Abstract LB018: Therapeutic efficacy of inhibition of specific sirtuins against melanoma in BrafV600E/PtenNULL and PDX models

Cancer Research

2023/4/14

A potential pro-oncogenic role of SERPINB4 in melanoma

Cancer Research

2023/4/4

Protective effects of dietary grape against atopic dermatitis-like skin lesions in NC/NgaTndCrlj mice

Frontiers in Immunology

2023/1/19

A homozygous missense variant in K25 underlying overlapping phenotype with woolly hair and dental anomalies

The Journal of investigative dermatology

2023/1

EPAC regulates melanoma growth by stimulating mTORC1 signaling and loss of EPAC signaling dependence correlates with melanoma progression

Molecular Cancer Research

2022/10/4

654 Novel immune-related proteins differentially expressed in melanoma

Journal of Investigative Dermatology

2022/8/1

652 EPAC-mTORC1 signaling regulates proliferation of primary melanoma cells and loss of dependence on EPAC signaling correlates with melanoma progression

Journal of Investigative Dermatology

2022/8/1

CRISPR/Cas9-mediated knockout of PLK4 results in antiproliferative response in human epidermoid carcinoma cells in vitro and in implanted xenografts

Cancer Research

2022/6/15

A tissue microarray study to validate key immune-related proteins in melanoma

Cancer Research

2022/6/15

Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice

Journal of Investigative Dermatology

2022/4/1

PLK1 inhibition-based combination therapies for cancer management

2022/2/1

A potential tumor suppressive role of polo-like kinase 5 in specific neoplasms

Cancer Research

2021/7/1

Potential correlations between PLK1, BRAF and MITF in melanoma

Cancer Research

2021/7/1

Role of polo-like kinase 4 (PLK4) in epithelial cancers and recent progress in its small molecule targeting for cancer management

2021/4/1

PLK1 and NOTCH positively correlate in melanoma and their combined inhibition results in synergistic modulations of key melanoma pathways

Molecular cancer therapeutics

2021/1/1

See List of Professors in Mary Ann Ndiaye University(University of Wisconsin-Madison)

Co-Authors

academic-engine